J&J Symposium on Therapeutic Peptides
With advancements in technology and research, therapeutic peptides are a promising treatment modality with the potential to address unmet medical needs and improve patient outcomes.
To bring together experts to debate over new developments and discoveries in the field, Johnson & Johnson is organizing an R&D Symposium on Therapeutic Peptides on Thursday, June 27th, in Beerse, Belgium.
This one-day symposium will focus on exciting advances in discovering and developing therapeutic peptides.Our invited speakers are experts from academia and industry, who will discuss peptide synthesis,new advances in oral delivery and cell permeability, success stories, and future perspectives:
• Andreas Bernkop-Schürch, University of Innsbruck, Austria• Christian Heinis, EPFL, Switzerland• Dani Schultz, Merck, USA• Kyungbo Kim, BioMedX Institute, Germany• Pius Baur, Johnson & Johnson, Switzerland• Steven Ballet, VUB Brussels, Belgium• Vijaya Pattabiraman, Bright peak, Switzerland• Gemma Mudd, Bicycle Therapeutics, UK
Register now on https://rndsymposium.be/